Preclinical pharmacokinetic study of a novel lipid-lowering agent, IMM-H007
Z.-L. Zhang, W.-Q. Liu, X.-Z. Deng Department of Pharmacy, Linyi City People’s Hospital, Linyi, China.
The article “Preclinical pharmacokinetic study of a novel lipid-lowering agent, IMM-H007, by Z.-L. Zhang, W.-Q. Liu, X.-Z. Deng, published in Eur Rev Med Pharmacol Sci 2018; 22 (24): 8939-8950–DOI: 10.26355/eurrev_201812_16664–PMID: 30575938” has been withdrawn from the authors stating that “after our article was published, we received a conflict of interest from the Chinese Academy of Sciences. They declared that they developed IMM-H007 for the first time and they had already applied for the patent. We had already cited in the references that IMM-H007 came from the Chinese Academy of Sciences. But they still insisted that we had violated their rights. We had to withdraw our paper in order to avoid greater conflicts and disputes”.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadPreclinical pharmacokinetic study of a novel lipid-lowering agent, IMM-H007
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Z.-L. Zhang, W.-Q. Liu, X.-Z. Deng
Preclinical pharmacokinetic study of a novel lipid-lowering agent, IMM-H007
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 21
Pages: 10913-10913
DOI: 10.26355/eurrev_202011_23544